NCT00025675 - Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

October 9, 2001

Primary Completion Date

July 5, 2006

Study Completion Date

January 2, 2010

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

gefitinib

Trial Locations (12)

Memorial Sloan-Kettering Cancer Center, New York

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

University of Wisconsin Comprehensive Cancer Center, Madison

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

UCSF Comprehensive Cancer Center, San Francisco

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

NCI - Neuro-Oncology Branch, Bethesda

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

University of Michigan Comprehensive Cancer Center, Ann Arbor

Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

M.D. Anderson Cancer Center at University of Texas, Houston

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER